|
1
|
Nagaya N, Kangawa K, Itoh T, et al:
Transplantation of mesenchymal stem cells improves cardiac function
in a rat model of dilated cardiomyopathy. Circulation.
112:1128–1135. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tse HF, Thambar S, Kwong YL, et al:
Prospective randomized trial of direct endomyocardial implantation
of bone marrow cells for treatment of severe coronary artery
diseases (PROTECT-CAD trial). Eur Heart J. 28:2998–3005. 2007.
View Article : Google Scholar
|
|
3
|
Müller-Ehmsen J, Krausgrill B, Burst V, et
al: Effective engraftment but poor mid-term persistence of
mononuclear and mesenchymal bone marrow cells in acute and chronic
rat myocardial infarction. J Mol Cell Cardiol. 41:876–884.
2006.PubMed/NCBI
|
|
4
|
Leobon B, Garcin I, Menasche P, Vilquin
JT, Audinat E and Charpak S: Myoblasts transplanted into rat
infarcted myocardium are functionally isolated from their host.
Proc Natl Acad Sci USA. 100:7808–7811. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grauss RW, van Tuyn J, Steendijk P, et al:
Forced myocardin expression enhances the therapeutic effect of
human mesenchymal stem cells after transplantation in ischemic
mouse hearts. Stem Cells. 26:1083–1093. 2008. View Article : Google Scholar
|
|
6
|
Hahn JY, Cho HJ, Kang HJ, et al:
Pre-treatment of mesenchymal stem cells with a combination of
growth factors enhances gap junction formation, cytoprotective
effect on cardiomyocytes, and therapeutic efficacy for myocardial
infarction. J Am Coll Cardiol. 51:933–943. 2008. View Article : Google Scholar
|
|
7
|
Rosová I, Dao M, Capoccia B, Link D and
Nolta JA: Hypoxic preconditioning results in increased motility and
improved therapeutic potential of human mesenchymal stem cells.
Stem Cells. 26:2173–2182. 2008.PubMed/NCBI
|
|
8
|
Contreras JE, Sánchez HA, Véliz LP,
Bukauskas FF, Bennett MV and Saéz JC: Role of connexin-based gap
junction channels and hemichannels in ischemia-induced cell death
in nervous tissue. Brain Res Brain Res Rev. 47:290–303. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasui K, Kada K, Hojo M, et al:
Cell-to-cell interaction prevents cell death in cultured neonatal
rat ventricular myocytes. Cardiovasc Res. 48:68–76. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giardina SF, Mikami M, Goubaeva F and Yang
J: Connexin 43 confers resistance to hydrogen peroxide-mediated
apoptosis. Biochem Biophys Res Commun. 362:747–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goubaeva F, Mikami M, Giardina S, Ding B,
Abe J and Yang J: Cardiac mitochondrial connexin 43 regulates
apoptosis. Biochem Biophys Res Commun. 352:97–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pijnappels DA, Schalij MJ, van Tuyn J, et
al: Progressive increase in conduction velocity across human
mesenchymal stem cells is mediated by enhanced electrical coupling.
Cardiovasc Res. 72:282–291. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu G, Haider HK, Jiang S and Ashraf M:
Sca-1+ stem cell survival and engraftment in the infarcted heart:
dual role for preconditioning-induced connexin-43. Circulation.
119:2587–2596. 2009.
|
|
14
|
Wang D, Shen W, Zhang F, Chen M, Chen H
and Cao K: Connexin43 promotes survival of mesenchymal stem cells
in ischemic heart. Cell Biol Int. 34:415–423. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Crisostomo PR, Wang Y, Markel TA, Wang M,
Lahm T and Meldrum DR: Human mesenchymal stem cells stimulated by
TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B-
but not JNK-dependent mechanism. Am J Physiol Cell Physiol.
294:C675–C682. 2008. View Article : Google Scholar
|
|
16
|
Yoon YS, Wecker A, Heyd L, et al: Clonally
expanded novel multipotent stem cells from human bone marrow
regenerate myocardium after myocardial infarction. J Clin Invest.
115:326–338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jia G, Cheng G, Gangahar DM and Agrawal
DK: Involvement of connexin 43 in angiotensin II-induced migration
and proliferation of saphenous vein smooth muscle cells via the
MAPK-AP-1 signaling pathway. J Mol Cell Cardiol. 44:882–890. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gnecchi M, He H, Noiseux N, et al:
Evidence supporting paracrine hypothesis for Akt-modified
mesenchymal stem cell-mediated cardiac protection and functional
improvement. FASEB J. 20:661–669. 2006. View Article : Google Scholar
|
|
19
|
Dai W, Hale SL, Martin BJ, et al:
Allogeneic mesenchymal stem cell transplantation in postinfarcted
rat myocardium: short- and long-term effects. Circulation.
112:214–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang S, Haider H, Idris NM, Salim A and
Ashraf M: Supportive interaction between cell survival signaling
and angiocompetent factors enhances donor cell survival and
promotes angiomyogenesis for cardiac repair. Circ Res. 99:776–784.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Evans WH and Leybaert L: Mimetic peptides
as blockers of connexin channel-facilitated intercellular
communication. Cell Commun Adhes. 14:265–273. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Martin PE, Wall C and Griffith TM: Effects
of connexin-mimetic peptides on gap junction functionality and
connexin expression in cultured vascular cells. Br J Pharmacol.
144:617–627. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hagen A, Dietze A and Dhein S: Human
cardiac gap-junction coupling: effects of antiarrhythmic peptide
AAP10. Cardiovasc Res. 83:405–415. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jansen JA, van Veen TA, de Bakker JM and
van Rijen HV: Cardiac connexins and impulse propagation. J Mol Cell
Cardiol. 48:76–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roell W, Lewalter T, Sasse P, et al:
Engraftment of connexin 43-expressing cells prevents post-infarct
arrhythmia. Nature. 450:819–824. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abraham MR, Henrikson CA, Tung L, et al:
Antiarrhythmic engineering of skeletal myoblasts for cardiac
transplantation. Circ Res. 97:159–167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Valiunas V, Doronin S, Valiuniene L, et
al: Human mesenchymal stem cells make cardiac connexins and form
functional gap junctions. J Physiol. 555:617–626. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hare JM, Traverse JH, Henry TD, et al: A
randomized, double-blind, placebo-controlled, dose-escalation study
of intravenous adult human mesenchymal stem cells (prochymal) after
acute myocardial infarction. J Am Coll Cardiol. 54:2277–2286. 2009.
View Article : Google Scholar
|
|
29
|
Balsam LB, Wagers AJ, Christensen JL,
Kofidis T, Weissman IL and Robbins RC: Haematopoietic stem cells
adopt mature haematopoietic fates in ischaemic myocardium. Nature.
428:668–673. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nygren JM, Jovinge S, Breitbach M, et al:
Bone marrow-derived hematopoietic cells generate cardiomyocytes at
a low frequency through cell fusion, but not transdifferentiation.
Nat Med. 10:494–501. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gnecchi M, He H, Liang OD, et al:
Paracrine action accounts for marked protection of ischemic heart
by Akt-modified mesenchymal stem cells. Nat Med. 11:367–368. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grunewald M, Avraham I, Dor Y, et al:
VEGF-induced adult neovascularization: recruitment, retention, and
role of accessory cells. Cell. 124:175–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Langer HF, Stellos K, Steingen C, et al:
Platelet derived bFGF mediates vascular integrative mechanisms of
mesenchymal stem cells in vitro. J Mol Cell Cardiol. 47:315–325.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu G, Haider HKh, Porollo A and Ashraf M:
Mitochondria-specific transgenic overexpression of connexin-43
simulates preconditioning-induced cytoprotection of stem cells.
Cardiovasc Res. 88:277–286. 2010. View Article : Google Scholar : PubMed/NCBI
|
